Efficacy of rebamipide for Functional Dyspepsia : Randomized, Double-Masked Comparative Study.

Efficacy of rebamipide for Functional Dyspepsia : Randomized, Double-Masked Comparative Study. - Efficacy of rebamipide for Functional Dyspepsia : Randomized, Double-Masked Comparative Study.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002305

Enrollment

Registered

2009-08-06

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

Oral administration of rebamipide 100mg three times daily for 2 weeks. Oral administration of placebo three times daily for 2 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a.Obtaining informed consent b.Patient of 20 years or more c.Patient during reflux esophagitis and gastritis during PPI mentenance therapy with dyspepsia.

Exclusion criteria

Exclusion criteria: The patient who collides with either the following assumes that it doesn't put it in to the examination 1) Drug allergy

Design outcomes

Primary

Measure	Time frame
Self-questionnaire for epigastric bloating etc.	—

Countries

Japan

Contacts

Public ContactMasahiko Inamori

Yokohama City University Graduate School of Medicine Gastroenterology Division

inamorim@med.yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026